PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
Application Deadline: 10/12/2018
Ref: PD-SMU
The Targeted therapeutics and nanodevices group led by Dr. Silvia Muro at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral candidate to work on the design of nanocarriers to transport drugs to the brain. The contract will be framed around a funded Explora Ciencia / Tecnología project, which aims to investigate the biological mechanisms controlling transport into and across the blood-brain barrier (BBB) to then design polymeric nanovehicles with optimal properties for brain delivery of therapeutics in the context of neurodegenerative diseases.
Application Deadline: 10/12/2018
Ref: PD-EM
The Biomimetic systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral Researcher candidate to to develop his/her project on the development of a physiological in vitro model of the intestinal epithelium from using organoid-derived cells.
The contract will be within the framework of the project “Engineering complex models of intestinal epithelium”, whose objective is the development of tissue-like models of intestinal tissue that can be used in basic research, disease modeling, host-pathogen interaction studies, and regenerative medicine.
Researchers at IBEC and IDIBELL have developed a light-regulated molecule that could improve chemotherapy treatments by controlling the activity of anticancer agents.Chemotherapy – the use of cytotoxic agents to kill the rapidly proliferating cells in tumors – is one of our main tools in the fight against cancer. However, its effectiveness and the body’s tolerance of it is often dramatically limited: it can affect healthy areas rather than just the cancerous ones, which causes side effects.
Today Spain’s Severo Ochoa Centres of Excellence – including IBEC – and the María de Maeztu Units of Excellence are at the CNIO in Madrid for 100xCiencia.3, the annual event of the SOMMa alliance.This year’s 100xCiencia is devoted to ‘Bringing Science and Society’, and IBEC is participating with a poster about its outreach activities.
As well as representatives from the research centres and units, the event is being attended by politicians, journalists and civic figures to debate about the different aspects of how and why science is important for society.
Yesterday Betevé’s Deuwatts programme featured IBEC’s Nuria Montserrat talking about organ regeneration.